NUR 210 / NUR210 Principles of Pharmacology Exam 4
Practice Test Actual 2025/2026 with Detailed
Rationales | 100% Verified | Pass Guaranteed – A+
Graded
SECTION 1: Pharmacokinetics & Pharmacodynamics (Questions
1–12)
Q1: A patient is prescribed an oral medication that undergoes extensive first-pass
metabolism in the liver. Which pharmacokinetic parameter is most significantly
reduced as a result?
A. Bioavailability
B. Volume of distribution
C. Half-life
D. Therapeutic index
Correct Answer: A
Rationale: First-pass metabolism significantly reduces the fraction of an orally
administered drug that reaches systemic circulation, thereby decreasing
bioavailability. Drugs with high first-pass extraction often require alternative routes of
administration to achieve therapeutic plasma concentrations.
Q2: A nurse is reviewing a drug's pharmacokinetic profile and notes a half-life of 8
hours. Approximately how many hours are required to reach steady-state plasma
concentration with continuous dosing?
A. 8 hours
,B. 16 hours
C. 24 hours
D. 40 hours
Correct Answer: D
Rationale: Steady-state plasma concentration is typically achieved after
approximately 5 half-lives of continuous dosing. With an 8-hour half-life, 5 × 8 = 40
hours are required to reach steady state, which is a fundamental principle for
determining appropriate dosing intervals and timing of therapeutic drug monitoring.
Q3: A patient receiving morphine for postoperative pain reports increased sedation
when concurrently taking a benzodiazepine. This interaction is best explained by
which pharmacodynamic concept?
A. Synergism
B. Potentiation
C. Antagonism
D. Tolerance
Correct Answer: A
Rationale: Synergism occurs when two drugs produce an effect greater than the sum
of their individual effects. Both morphine and benzodiazepines cause central
nervous system depression; combined administration produces enhanced sedation
and respiratory depression beyond what either drug would produce alone.
Q4: A drug has an ED₅₀ of 10 mg and an LD₅₀ of 100 mg. What is the therapeutic
index, and what does it indicate about the drug's safety margin?
A. 10; narrow safety margin
B. 10; wide safety margin
C. 0.1; narrow safety margin
D. 90; wide safety margin
, Correct Answer: B
Rationale: The therapeutic index is calculated as LD₅₀ ÷ ED₅₀, which equals 100 ÷ 10
= 10. A therapeutic index of 10 indicates a relatively wide safety margin, meaning the
lethal dose is ten times greater than the effective dose, providing a reasonable buffer
between therapeutic and toxic effects.
Q5: A patient with liver cirrhosis is prescribed a drug that is primarily metabolized by
hepatic cytochrome P450 enzymes. Which adjustment should the nurse anticipate?
A. Increased loading dose
B. Decreased maintenance dose
C. Increased dosing frequency
D. No dose adjustment needed
Correct Answer: B
Rationale: Hepatic impairment reduces cytochrome P450 enzyme activity and
decreases hepatic blood flow, leading to impaired drug metabolism and
accumulation. A decreased maintenance dose is necessary to prevent toxicity while
still achieving therapeutic plasma concentrations in patients with liver cirrhosis.
Q6: A highly lipophilic drug is administered to an obese patient. Which
pharmacokinetic parameter is most likely to be increased?
A. Renal clearance
B. Volume of distribution
C. Bioavailability
D. Protein binding
Correct Answer: B
Rationale: Lipophilic drugs distribute extensively into adipose tissue, which increases
the volume of distribution. In obese patients, this can lead to prolonged drug effects
Practice Test Actual 2025/2026 with Detailed
Rationales | 100% Verified | Pass Guaranteed – A+
Graded
SECTION 1: Pharmacokinetics & Pharmacodynamics (Questions
1–12)
Q1: A patient is prescribed an oral medication that undergoes extensive first-pass
metabolism in the liver. Which pharmacokinetic parameter is most significantly
reduced as a result?
A. Bioavailability
B. Volume of distribution
C. Half-life
D. Therapeutic index
Correct Answer: A
Rationale: First-pass metabolism significantly reduces the fraction of an orally
administered drug that reaches systemic circulation, thereby decreasing
bioavailability. Drugs with high first-pass extraction often require alternative routes of
administration to achieve therapeutic plasma concentrations.
Q2: A nurse is reviewing a drug's pharmacokinetic profile and notes a half-life of 8
hours. Approximately how many hours are required to reach steady-state plasma
concentration with continuous dosing?
A. 8 hours
,B. 16 hours
C. 24 hours
D. 40 hours
Correct Answer: D
Rationale: Steady-state plasma concentration is typically achieved after
approximately 5 half-lives of continuous dosing. With an 8-hour half-life, 5 × 8 = 40
hours are required to reach steady state, which is a fundamental principle for
determining appropriate dosing intervals and timing of therapeutic drug monitoring.
Q3: A patient receiving morphine for postoperative pain reports increased sedation
when concurrently taking a benzodiazepine. This interaction is best explained by
which pharmacodynamic concept?
A. Synergism
B. Potentiation
C. Antagonism
D. Tolerance
Correct Answer: A
Rationale: Synergism occurs when two drugs produce an effect greater than the sum
of their individual effects. Both morphine and benzodiazepines cause central
nervous system depression; combined administration produces enhanced sedation
and respiratory depression beyond what either drug would produce alone.
Q4: A drug has an ED₅₀ of 10 mg and an LD₅₀ of 100 mg. What is the therapeutic
index, and what does it indicate about the drug's safety margin?
A. 10; narrow safety margin
B. 10; wide safety margin
C. 0.1; narrow safety margin
D. 90; wide safety margin
, Correct Answer: B
Rationale: The therapeutic index is calculated as LD₅₀ ÷ ED₅₀, which equals 100 ÷ 10
= 10. A therapeutic index of 10 indicates a relatively wide safety margin, meaning the
lethal dose is ten times greater than the effective dose, providing a reasonable buffer
between therapeutic and toxic effects.
Q5: A patient with liver cirrhosis is prescribed a drug that is primarily metabolized by
hepatic cytochrome P450 enzymes. Which adjustment should the nurse anticipate?
A. Increased loading dose
B. Decreased maintenance dose
C. Increased dosing frequency
D. No dose adjustment needed
Correct Answer: B
Rationale: Hepatic impairment reduces cytochrome P450 enzyme activity and
decreases hepatic blood flow, leading to impaired drug metabolism and
accumulation. A decreased maintenance dose is necessary to prevent toxicity while
still achieving therapeutic plasma concentrations in patients with liver cirrhosis.
Q6: A highly lipophilic drug is administered to an obese patient. Which
pharmacokinetic parameter is most likely to be increased?
A. Renal clearance
B. Volume of distribution
C. Bioavailability
D. Protein binding
Correct Answer: B
Rationale: Lipophilic drugs distribute extensively into adipose tissue, which increases
the volume of distribution. In obese patients, this can lead to prolonged drug effects
